medigraphic.com
SPANISH

Revista Médica Electrónica

ISSN 1684-1824 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 1

<< Back Next >>

Rev Méd Electrón 2019; 41 (1)

Survival in women with breast cancer. Hospital “Jose Ramon Lopez Tabrane”.Province of Matanzas. 2010-2015

García SJ, Busto HJ, Hernández MM, Schery GO, García BJA
Full text How to cite this article

Language: Spanish
References: 17
Page: 118-129
PDF size: 3005.74 Kb.


Key words:

breast cancer, global survival, retrospective, longitudinal, observational descriptive study.

ABSTRACT

Introduction: in the last three years, mortality rates due to breast cancer in the female sex in Cuba slightly decreased, but studies of this disease survival have not been carried out in the province of Matanzas.
Objective: to evaluate the behavior of the global survival time of this series at the 5th year and to assess survival according to chosen variables.
Material and method: a retrospective, longitudinal, observational descriptive study was carried out; 288 women diagnosed with breast cancer took part on it; they were diagnosed in the mastology consultation of the hospital “Jose Ramon Lopez Tabrane”, province of Matanzas during the period January 1st 2010- December 31st 2015. The Kaplan-Meier method was used to determine the global survival time at the 5th year according to chosen variables. The comparison of the different curves for the exposition variables was made using the Log Rank test. The test value higher than 1 and p < 0.05 was considered statistically significant.
Results: global survival at the 5th year was 66 %. There are survival rates well below the international standards for the stage III (37 %) and stage IV (0) patients. Global survival significantly decreases insofar as the number of affected ganglia and the size of the tumor at the moment of the diagnosis increase.
Conclusions: global survival at the 5th year was lower than the one recorded in most of the consulted international studies. There is a remarkable decrease of survival in patients with disease advanced clinical stages: III and IV.


REFERENCES

  1. Engel JM, Stankowski-Drengler TJ, Stankowski RV, et al. All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol. 2015;204(4):898-902. Citado en PubMed; PMID: 25794084.

  2. Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2014. Ann Oncol. 2014;25(8):1650-6. Citado en PubMed; PMID: 24759568.

  3. Allemani C, Weir HK, Coleman MP, et al. CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010. Citado en PubMed; PMID: 25467588.

  4. Ministerio de Salud Pública. Anuarios Estadísticos 2015, 2016 y 2017. Mortalidad por tumores malignos en el sexo femenino según localización y grupo de edad. La Habana: MINSAP; 2018.

  5. De Angelis R, Coleman MP, Capocaccia R, et al. EUROCARE-5 Working Group. Cancer survival in Europe 19992007 by country and age: results of EUROCARE 5 - a population-based study. Lancet Oncol. 2014;15(1):23-34. Citado en PubMed; PMID: 24314615.

  6. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010. p. 347-76.

  7. World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1. IARC CancerBase No.11 [Internet]. Ginebra: WHO; 2012 [citado 23/09/2018]. Disponible en: http://publications.iarc.fr/Databases/Iarc-Cancerbases/GLOBOCAN-2012- Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0- 2012

  8. De Freitas R, Disconzi R, Martins E, et al. Prognostic factors and overall survival of breast cancer in the city of Goiania, Brazil: a population-based study. Rev Col Bras Cir. 2017;44(5):435-443. Citado en PubMed; PMID: 29019571.

  9. Carneseca EC, Mauad EC, Araujo MA, et al. The Hospital de Câncer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10- year period. BMC Res Notes. 2013;6:141-51. Citado en PubMed; PMID: 23574710.

  10. Unger-Saldaña K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465-77. Citado en PubMed; PMID: 25114860.

  11. Freitas-JR, Rodríguez DC, Corrêa RD, et al. Contribution of the Unified Health Care System to mammography screening in Brazil, 2013. Radiol Bras [Internet]. 2016 [citado 23/09/2018];49(5):305-10. Disponible en: http://www.scielo.br/pdf/rb/v49n5/0100-3984-rb-49-05-0305.pdf

  12. Álvarez MT, Rosado LM, Morales J, et al. Prognostic Factors Associated with Survival in Women with Breast Cancer from Veracruz, México. J Cancer Sci Ther [Internet]. 2016 [citado 23/09/2018];8:092-098. Disponible en:https://www.omicsonline.org/open-access/prognostic-factors-associated-withsurvival- in-women-with-breast-cancerfrom-veracruz-mexico-1948-5956- 1000398.php?aid=72454

  13. Maffuz A, Labastida S, Sherwell S, et al. Supervivencia de pacientes con cáncer de mama. Análisis por factores pronóstico, clínicos y patológicos. Ginecol Obstet Mex [Internet]. 2016 [citado 23/09/2018];84(8):498-506. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2016/gom168e.pdf

  14. Sathwara J, Bobdey S, Ganesh B. Breast cancer survival studies in India: a review. Int J Res Med Sci [Internet]. 2016 [citado 23/09/2018];4(8):3102-8. Disponible en: https://www.msjonline.org/index.php/ijrms/article/view/1084

  15. Rodríguez YM, Delisle G, Sagaró NM, et al. Factores pronósticos y supervivencia de mujeres con cáncer de mama en Santiago de Cuba. MEDISAN [Internet]. 2018 [citado 23/09/2018];(22):5. Disponible en:http://www.medisan.sld.cu/index.php/san/article/view/1841

  16. González L, Lemes J. Supervivencia del cáncer de mama. Archivo Médico de Camagüey [Internet]. 2011 [citado 23/09/2018];15(6):972-981. Disponible en: https://www.redalyc.org/pdf/2111/211121510006.pdf

  17. Baulies Caballero S, Xercavins Montosa X, Cusidó Gimferrer M. Factores predictivos de respuesta a la quimioterapia neoadyuvante en cáncer de mama [Tesis doctoral en Internet]. Barcelona: Universidad Autónoma de Barcelona; 2014 [citado 23/09/2018]. Disponible en: https://ddd.uab.cat/record/127085




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Méd Electrón. 2019;41